Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions. 2019

Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
Department of Surgical, Oncological and Oral Sciences, Section of Plastic and Reconstructive Surgery, University of Palermo, 90127 Palermo, Italy; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 90127 Palermo, Italy. Electronic address: annabarbara.distefano@gmail.com.

Angiogenesis is a crucial process for the maintenance of normal tissue physiology and it is involved in tissue remodeling and regeneration. This process is essential for adipose tissue maintenance. The adipose tissue is composed by different cell types including stromal vascular cells as well as adipose stem cells (ASCs). In particular, ASCs are multipotent somatic stem cells that are able to differentiate and secrete several growth factors; they are recently emerging as a new cell reservoir for novel therapies and strategies in many diseases. Several studies suggest that ASCs have peculiar properties and participate in different disease-related processes such as angiogenesis. Furthermore, pathological expansion of adipose tissue brings to hypoxia, a major condition of unhealthy angiogenesis. Recent evidences have shown that microRNAs (miRNAs) play a crucial role also on ASCs as they take part in stemness maintenance, proliferation, and differentiation. It has been suggested that some miRNAs (MIR126, MIR31, MIR221 MIR222, MIR17-92 cluster, MIR30, MIR100 and MIR486) are directly involved in the angiogenic process by controlling multiple genes involved in this pathway. With the present review, we aim at providing an updated summary of the importance of adipose tissue under physiological and pathological conditions and of its relationship with neovascularization process. In particular, we report an overview of the most important miRNAs involved in angiogenesis focusing on ASCs. Hopefully the data presented will bring benefit in developing new therapeutic strategies.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D018919 Neovascularization, Physiologic The development of new BLOOD VESSELS during the restoration of BLOOD CIRCULATION during the healing process. Angiogenesis, Physiologic,Angiogenesis, Physiological,Neovascularization, Physiological,Physiologic Angiogenesis,Physiologic Neovascularization,Physiological Angiogenesis,Physiological Neovascularization
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
May 2020, Angiogenesis,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
January 1991, Haematologica,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
January 2021, Frontiers in physiology,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
January 2024, Endocrine,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
October 2012, Joint bone spine,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
June 1971, Archiv fur Gynakologie,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
January 2002, Der Orthopade,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
January 1996, Prostaglandins, leukotrienes, and essential fatty acids,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
January 2014, BioMed research international,
Anna Barbara Di Stefano, and Daniela Massihnia, and Federica Grisafi, and Marta Castiglia, and Francesca Toia, and Luigi Montesano, and Antonio Russo, and Francesco Moschella, and Adriana Cordova
November 1960, Acta medica Scandinavica,
Copied contents to your clipboard!